Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Infectious Diseases

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/430742PMID 15942890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy

  2005cited by this paper
• Comparison of Nevirapine (NVP) Resistance in Ugandan Women 7 Days vs. 6–8 Weeks after Single-Dose NVP Prophylaxis: HIVNET 012

  2004cited by this paper
• Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants

  2004cited by this paper
• Characterization of Nevirapine Resistance Mutations in Women With Subtype A Vs. D HIV-1 6–8 Weeks After Single-Dose Nevirapine (HIVNET 012)

  2004cited by this paper
• LigAmp for sensitive detection of single-nucleotide differences

  2004cited by this paper
• Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

  2004cited by this paper
• Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.

  2002cited by this paper
• Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)

  2001cited by this paper
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

  1999cited by this paper
• Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase.

  1998cited by this paper

• The Origins and Genetic Diversity of HIV-1: Evolutionary Insights and Global Health Perspectives

  2025cites this paper
• Retired Nurses Can Improve Retention in Prevention of Mother-to-Child Transmission Programmes

  2019cites this paper
• Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

  2019cites this paper
• Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.

  2019cites this paper
• Incidence and Risk Factors for Overweight and Obesity after Initiation of Antiretroviral Therapy in Dar es Salaam, Tanzania

  2018cites this paper
• The clarifying role of time series data in the population genetics of HIV

  2018cites this paper
• Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort

  2018cites this paper
• The Role of HIV‐1 Drug‐Resistant Minority Variants in Treatment Failure

  2017cites this paper
• Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States

  2017cites this paper
• Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT

  2017cites this paper
• HIV-1 Resistance to the Nonnucleoside Reverse Transcriptase Inhibitors

  2017cites this paper
• The impact of antiretroviral therapy used in pregnancy on the health of HIV-positive women

  2016influential citation
• Shift From PMTCT Program to ART Program.

  2015cites this paper
• Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique

  2015cites this paper
• Editorial

  2015cites this paper
• Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy

  2015cites this paper
• Characterizing protease inhibitor failure in HIV-1 subtype C, using ultra deep pyro-sequencing and homology modelling.

  2015cites this paper
• Notes on the road to perfection; use of nevirapine in combination antiretroviral therapy for children with perinatal nevirapine exposure.

  2015cites this paper
• Development of amplification-based technologies for enrichment of nucleic acids with difficult sequences or low-abundance point mutations

  2015cites this paper
• Population and single genome kinetics driving the evolution of multiple linked multiclass drug resistance mutations in the viral protease and reverse transcriptase of HIV-1 subtype C in children receiving early protease inhibitor based combination therapy

  2015cites this paper
• HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

  2014cites this paper
• Combination Antiretroviral Treatment for Women Previously Treated Only in Pregnancy: Week 24 Results of AIDS Clinical Trials Group Protocol A5227

  2014cites this paper
• A descriptive study of outcomes of interventions to prevent mother to child transmission of HIV in two primary health care centres in Lusaka, Zambia

  2013cites this paper
• Extensive Drug Resistance in HIV-Infected Cambodian Children Who Are Undetected as Failing First-Line Antiretroviral Therapy by WHO 2010 Guidelines

  2013cites this paper
• An Examination of Non-Nucleoside Reverse Transcriptase Inhibitors

  2013cites this paper
• Chapter 2 The 2008 status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa

  2013cites this paper
• Simultaneous Detection of Major Drug Resistance Mutations in the Protease and Reverse Transcriptase Genes for HIV-1 Subtype C by Use of a Multiplex Allele-Specific Assay

  2013cites this paper
• Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention

  2013influential citation
• Clinical implications of HIV-1 minority variants.

  2013cites this paper
• Drug-resistant HIV-1 in sub-Saharan Africa : clinical and public health studies Hamers

  2013cites this paper
• Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children

  2013cites this paper
• Vertikale HIV-Transmission im ländlichen Tansania : Herausforderungen bei der Umsetzung eines komplexen antiretroviralen

  2013influential citation
• Reverse Transcriptase Genes for HIV-1 Subtype C Using a Multiplex Allele-

  2013cites this paper
• HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.

  2013cites this paper
• Dynamics of drug resistance development in HIV- positive Ugandan mother-child pairs during 18 months after nevirapine single-dose exposure for PMTCT

  2013cites this paper
• Allele-Specific Assay Subtype C by Use of a Multiplex Reverse Transcriptase Genes for HIV-1 Resistance Mutations in the Protease and Simultaneous Detection of Major Drug

  2013cites this paper
• Low-Frequency Nevirapine Resistance at Multiple Sites May Predict Treatment Failure in Infants on Nevirapine-Based Treatment

  2012cites this paper
• The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs

  2012cites this paper
• Ultrasensitive Allele-Specific PCR Reveals Rare Preexisting Drug-Resistant Variants and a Large Replicating Virus Population in Macaques Infected with a Simian Immunodeficiency Virus Containing Human Immunodeficiency Virus Reverse Transcriptase

  2012cites this paper
• Molecular characterization of HIV-1 drug resistance mutations among ARV-treated female commercial sex workers in a Nairobi cohort

  2012cites this paper
• Prevention on Parent to Child Transmission of HIV – What is New?

  2012cites this paper
• Virologic determinants of breast milk transmission of HIV-1.

  2012cites this paper
• Short-Course Combivir after Single-Dose Nevirapine Reduces but Does Not Eliminate the Emergence of Nevirapine Resistance in Women

  2012cites this paper
• Antiviral Drugs - Aspects of Clinical Use and Recent Advances

  2012cites this paper
• Recherche et évaluation des stratégies de prise en charge précoce de l’enfant infecté par le VIH en Afrique de l’Ouest : accès, efficacité, et déterminants

  2012cites this paper
• Setting up of HIV-1 Antiretroviral resistance testing methods and their clinical applications.

  2012cites this paper
• Use of Animal Models for Anti-HIV Drug Development

  2012cites this paper
• The utility of molecular diagnostics to predict recurrence of head and neck carcinoma

  2012cites this paper
• Minority HIV‐1 resistant variants in recent infection and in patients who failed first‐line antiretroviral therapy with no detectable resistance‐associated mutations in Thailand

  2012cites this paper
• Emergence of Minor Drug-Resistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission

  2012cites this paper
• Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children.

  2011cites this paper
• Human immunodeficiency virus type 1 mother‐to‐child transmission and prevention: successes and controversies

  2011cites this paper
• The effects of highly active antiretroviral therapy on survival and CD4 cell percentage in HIV-infected children in Kinshasa, Democratic Republic of Congo

  2011cites this paper
• Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

  2011cites this paper
• New technology to detect low-level drug-resistant HIV variants

  2011influential citation
• Development of antiretroviral drug resistance.

  2011cites this paper
• CHAPTER 21 – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant

  2011cites this paper
• The Changing Trends of HIV Subtypes and Its Implication on Mother-to-Child Transmission

  2011cites this paper
• Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine

  2011cites this paper
• Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis

  2011cites this paper
• The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort Study

  2011cites this paper
• The role of the HIV-1 reverse transcriptase mutation H208Y to drug resistance and viral fitness

  2011cites this paper
• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

  2011cites this paper
• Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine

  2011cites this paper
• Antiretroviral therapies in women after single-dose nevirapine exposure.

  2010cites this paper
• Vertical Transmission of HIV–An Update

  2010cites this paper
• Ultrasensitive Detection of Minor Drug-Resistant Variants for HIV After Nevirapine Exposure Using Allele-Specific PCR: Clinical Significance

  2010cites this paper
• Minority variants of drug-resistant HIV.

  2010cites this paper
• Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs

  2010cites this paper
• Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy.

  2010cites this paper
• Use of HIV Resistance Testing After Prolonged Treatment Interruption

  2010cites this paper
• Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.

  2010cites this paper
• Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.

  2010cites this paper
• Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

  2010cites this paper
• Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance.

  2010cites this paper
• HIV drug resistance and mother-to-child transmission of HIV.

  2010cites this paper
• Estimating Frequencies of Minority Nevirapine-Resistant Strains in Chronically HIV-1-Infected Individuals Naïve to Nevirapine by Using Stochastic Simulations and a Mathematical Model

  2010cites this paper
• Peripartum nevirapine exposure and subsequent clinical outcomes among HIV‐infected women receiving antiretroviral therapy for at least 12 months

  2010cites this paper
• UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL

  2010cites this paper
• Prevention of vertical transmission of HIV-1 in resource-limited settings

  2010cites this paper
• Université Victor Segalen Bordeaux 2

  2010cites this paper
• Analysis of Drug Resistance in Children Receiving Antiretroviral Therapy for Treatment of HIV-1 Infection in Uganda

  2010cites this paper
• Detection of HIV-1 Drug Resistance in Women Following Administration of a Single Dose of Nevirapine: Comparison of Plasma RNA to Cellular DNA by Consensus Sequencing and by Oligonucleotide Ligation Assay

  2010cites this paper
• HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays.

  2010cites this paper
• Effectiveness of Non-nucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Women Previously Exposed to a Single Intrapartum Dose of Nevirapine: A Multi-country, Prospective Cohort Study

  2010cites this paper
• Adverse events and placebo effects: African scientists, HIV, and ethics in the ‘global health sciences’

  2010cites this paper
• Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.

  2009cites this paper
• Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.

  2009cites this paper
• Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature

  2009cites this paper
• Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use

  2009cites this paper
• Clinical Implications of HIV-1 Drug Resistance

  2009cites this paper
• Validation of replicative phenotyping to detect and assign HIV-1 resistance in clinical specimens

  2009cites this paper
• The Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation I132M Confers Hypersensitivity to Nucleoside Analogs

  2009cites this paper
• The effeciveness and determinants of effectiveness of antiretroviral therapy for adults in the Western Cape Province, South Africa

  2009cites this paper
• Intrapartum Tenofovir and Emtricitabine Reduces Low-Concentration Drug Resistance Selected by Single-Dose Nevirapine for Perinatal HIV Prevention

  2009cites this paper
• Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.

  2009cites this paper
• Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

  2009cites this paper
• Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.

  2009cites this paper
• Application of an allele‐specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patients

  2009influential citation
• German-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008

  2009cites this paper